Overview
Pancreatic Cancer Detection Consortium (PCDC) 8th Annual Steering Committee Meeting
Date and Time:
Day 1: December 11th from 9:00 am – 6:30 pm ET
Day 2: December 12th from 08:00 am – 1:00 pm ET
Location: Hybrid Meeting
This is a hybrid meeting, with both in-person and virtual viewing options. Attendees are encouraged to participate in person if possible. Day 1 is open to NCI staff and members of PCDC. Registration is required. The meeting will be at NCI Shady Grove Building, 9609 Medical Center Dr., Rockville, MD 20850.
Meeting Description: The Pancreatic Cancer Detection Consortium (PCDC) develops and tests new molecular and imaging biomarkers to detect early stage pancreatic ductal adenocarcinoma (PDAC) and its precursor lesions. These biomarkers would be used to identify individuals who are at high risk of developing PDAC and are candidates for early intervention.
Keynote Speaker: David Lyden, M.D., Ph.D., Weill Cornell Medicine